AI-generated summary
The authors reviewed randomized clinical trials of photobiomodulation for diabetic foot ulcers published between 2014 and 2019 and found seven eligible studies. They report that most did not describe their treatment parameters in detail, and that none reached the maximum methodological quality score. The studies used 600 nm and 800 nm wavelengths, and the authors conclude that parameters need further analysis to optimize treatment.
- Studies included
- 7
- Who or what was studied
- Humans with diabetic foot ulcers enrolled in randomized clinical trials
- Wavelengths
- 600, 800 nm
- Limits stated in the abstract
- The abstract reports that most included studies lacked detailed parameter descriptions and that none achieved the maximum Jadad quality score.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Systematic review, Meta-analysis, Wavelength, Low-level laser therapy, Wound healing, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.